Skip to main content

This section of the website is intended for Healthcare Professionals in the EEA only

If you are a patient being prescribed Coagadex®

Enter the Patient area

Bio Products Laboratory (BPL) have developed a Human Coagulation Factor X concentrate specifically for Factor X deficient patients.

Coagadex® (Human Coagulation Factor X) is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency, an ultra-rare disease.

Access to our medicine may vary depending on the country.

Medical information and adverse event reporting

For medical information:

Please call +44 (0) 208 957 2255 or email: [email protected]

Adverse events:

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

Adverse events should be reported to BPL Medical Department at: [email protected] or call +44 (0) 208 957 2622 (Mon-Fri 09:00-17:00 UK time) To report an adverse event outside these hours, please call +44 (0) 208 957 2200.

Healthcare professionals are also asked to report any suspected adverse reactions to their National Competent Authority. Information can be downloaded from the EMA website here:

DOWNLOAD THE REPORTING APPENDIX HERE

Summary of product characteristics

Coagadex Summary of Products Characteristics can be found on the EMA website

Read the EPAR in English or select the language in which you want to read them VIEW THE COAGADEX PRESCRIBING INFORMATION